BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35716358)

  • 1. Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.
    Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
    Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 4. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
    Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
    Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
    Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
    Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
    JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on Cancer staging systems.
    Elbasan O; Gogas Yavuz D
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):261-273. PubMed ID: 36756784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Value of Lymph Node Ratio Integration with the 8
    Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
    Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
    Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
    Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
    Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
    Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
    Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do
    Mukhtar N; Alhamoudi K; Alswailem M; Alhindi H; Murugan AK; Alghamdi B; Alzahrani AS
    Front Endocrinol (Lausanne); 2023; 14():1270796. PubMed ID: 37859987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
    van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; van Balkum M; Verburg FA; Visser WE
    J Clin Endocrinol Metab; 2023 May; 108(6):e267-e274. PubMed ID: 36508298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
    Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
    Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.